Assetmark, Inc

SEC CIK: 0001344551
Latest filing: Jul 30, 2026

SEC filings (opens in a new tab)

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overview All 13F holders of CLDX Full Q2 2026 holdings

Shares (Q2 2026): 21
Value: $781
% of portfolio: <0.1%
Quarters held: 4; Since Q2 2024

Holdings of CLDX by Assetmark, Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	21	$781	<0.1%	00.0%	Unchanged	Holders
Q1 2026	21	$666	<0.1%	+21	New	Holders
Q4 2024	0	$0	0.0%	−1−100.0%	Sold out	Holders
Q3 2024	1	$34	<0.1%	00.0%	Unchanged	Holders
Q2 2024	1	$37	<0.1%	+1	New	Holders